Status:
COMPLETED
Hepatitis C Virus and the Humoral Immune System
Lead Sponsor:
Rockefeller University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
New York Presbyterian Hospital
Conditions:
Hepatitis C Virus
Eligibility:
All Genders
Brief Summary
The purpose of this study is to measure specific chemokines, antibodies, and antibody-producing B cells in the blood of patients with hepatitis C virus (HCV) infection. Our hypothesis is that changes ...
Detailed Description
The long-term goal of our research is to understand why immune complexes (ICs) are produced in patients infected with HCV, and whether these complexes affect virus interaction with target cells. We ha...
Eligibility Criteria
Inclusion
- Healthy volunteers, no liver disease
- Chronic infection with hepatitis C virus
- Other chronic liver disease unrelated to hepatitis C virus
- Subjects in all groups must have sufficiently healthy veins to allow blood collection.
Exclusion
- Any medical condition that, in the opinion of the investigators, precludes the patient's participation
Key Trial Info
Start Date :
September 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT00219999
Start Date
September 1 2001
End Date
May 1 2013
Last Update
August 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rockefeller University Hosital
New York, New York, United States, 10021